Chromophobe renal cell carcinoma

Revision as of 06:35, 29 July 2016 by Banumathygowrishankar (talk | contribs) (→‎Contributors)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Contributors

Daynna Wolff PhD FACMG Yajuan Liu, PhD Rajyasree Emmadi, MD Banumathy Gowrishankar, PhD Jane Houldsworth, PhD

Tumor Type

Tumor Classification

Description

IHC Markers

Genomic Gain/Loss/LOH

Chromosome	Gain/Loss/Amp	Region
1	Loss	Chr1
2	Loss	Chr14
3	Loss	Chr21
4	Loss	ChrX
5	Loss	ChrY (male)

Rearrangements

Mutations (SNV/INDEL)

From Cosmic Mutated in >20%

Mutated in 10-20%

Mutated in 5-10%

Mutated in 2-5%

mtDNA

Epigenomics (methylation)

Main Pathways Involved

Diagnosis

Prognosis

Therapeutics

Familial Forms

Links

References

Retrieved from "https://ccga.io/index.php?title=Chromophobe_renal_cell_carcinoma&oldid=1515"